Literature DB >> 27033427

Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US.

Pratik P Rane1, Sushovan Guha2, Satabdi Chatterjee3, Rajender R Aparasu4.   

Abstract

BACKGROUND: Proton pump inhibitors (PPIs) can lead to several adverse effects among the elderly, particularly when used inappropriately or in contrast to evidence suggested protocols.
OBJECTIVE: The aim of this study was to examine the prevalence and predictors of non-evidence based PPI use in elderly nursing home residents.
METHODS: A cross-sectional study was conducted using data from the 2004 National Nursing Home Survey (NNHS). The study sample included nursing home residents 65 years and older. Descriptive statistics were used to examine the prevalence of non-evidence based PPI use. Multivariable logistic regression was used to evaluate the patient and facility-level factors associated with non-evidence based PPI use among the elderly nursing home residents.
RESULTS: A total of 355,600 elderly nursing home residents received at least one PPI for an overall prevalence of 26.99%. Among those elderly receiving PPIs, 48.59% of the use was not evidence based. Multivariable logistic regression revealed that residents with osteoporosis (Odds Ratio (OR): 0.55, 95% CI: 0.45-0.68), SSRI users (OR: 0.81, 95% CI: 0.68-0.97) and those residing in micropolitan area (OR: 0.79, 95% CI: 0.63-0.98) were negatively associated with prescription of PPIs without an indication. Patients with chronic cough (OR: 2.10, 95% CI: 1.12-3.96) and Medicare insurance (OR: 1.23, 95% CI: 1.01-1.50) were positively associated with prescription of PPIs without an indication.
CONCLUSIONS: The current study found that almost half of the elderly nursing home residents used PPIs for non-evidence based indications. Given the safety concerns and high non-evidence based use of PPIs in nursing homes, there is an urgent need to optimize PPI use in the elderly.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Elderly; Indication; Nursing home; Proton pump inhibitor

Mesh:

Substances:

Year:  2016        PMID: 27033427     DOI: 10.1016/j.sapharm.2016.02.012

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  20 in total

Review 1.  GERD Management: The Case for Lifestyle in an Era of PPIs.

Authors:  Joelle Ayoub; Nicole D White
Journal:  Am J Lifestyle Med       Date:  2017-01-10

2.  Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.

Authors:  Kate N Wang; J Simon Bell; Edwin C K Tan; Julia F M Gilmartin-Thomas; Michael J Dooley; Jenni Ilomäki
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

3.  Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.

Authors:  Shelly L Gray; Rod L Walker; Sascha Dublin; Onchee Yu; Erin J Aiello Bowles; Melissa L Anderson; Paul K Crane; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2017-11-14       Impact factor: 5.562

Review 4.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

5.  Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease.

Authors:  Heidi Juntunen; Heidi Taipale; Antti Tanskanen; Anna-Maija Tolppanen; Jari Tiihonen; Sirpa Hartikainen; Miia Tiihonen
Journal:  Eur J Clin Pharmacol       Date:  2017-06-02       Impact factor: 2.953

6.  Is There a Reason for the Proton Pump Inhibitor? An Assessment of Prescribing for Residential Care Patients in British Columbia.

Authors:  Adriel Chan; Libby Liang; Anthony C H Tung; Angus Kinkade; Aaron M Tejani
Journal:  Can J Hosp Pharm       Date:  2018-10-31

7.  Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.

Authors:  John P Haran; Beth A McCormick
Journal:  Gastroenterology       Date:  2020-12-08       Impact factor: 22.682

8.  Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1,322 patients with hepatitis C infection.

Authors:  Nancy Reau; Michael N Robertson; Hwa-Ping Feng; Luzelena Caro; Wendy W Yeh; Bach-Yen T Nguyen; Janice Wahl; Eliav Barr; Peggy Hwang; Stephanie O Klopfer
Journal:  Hepatol Commun       Date:  2017-08-22

9.  The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research.

Authors:  Ling-Ling Zhu; Quan Zhou
Journal:  Clin Interv Aging       Date:  2016-06-16       Impact factor: 4.458

10.  Prevalence and Variability in Medications Contributing to Polypharmacy in Long-Term Care Facilities.

Authors:  Natali Jokanovic; Kris M Jamsen; Edwin C K Tan; Michael J Dooley; Carl M Kirkpatrick; J Simon Bell
Journal:  Drugs Real World Outcomes       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.